首页 正文

Advancing therapeutic frontiers: a pipeline of novel drugs for UC management

{{output}}
Ulcerative colitis is a chronic inflammatory bowel disease with rising global prevalence. Despite therapeutic advances including biologic agents targeting tumor necrosis factor-alpha, integrins, and interleukin pathways, alongside Janus kinase inhibitors and s... ...